Anti-tumor necrosis factor alpha therapy, Adalimumab, in Rasmussen's encephalitis. (June 2017) - Villeneuve, N.; Lagarde, S.; Lepine, A.; Laguitton, V.; Bulteau, C.; Roubertie, A.; Barthez, M.A.; Trommsdorff, V.; Lefranc, J.; Des Portes, V.; Quartier, P.; Wehbi, S.; et al.